Savvy Updates, 5/17/21: Bigfoot Biomedical Smart Cap, T1D and Microbiome, Smallest Injectable Chip, New Rx Bottle Design, Rethinking Carb-Insulin Model, Neuropeptide Y, 3-D Printed Vitamins, and Breathing Oxygen
FDA clears novel smart cap for insulin pens was posted on Healio.com/endocrinology, 10 May 2021. The FDA granted 510(k) clearance for a first-of-its-kind connected smart cap for insulin pens, recommending insulin doses for people with diabetes prescribed...
Savvy Pets, 5/14/21: Meet Cabot … she’s simply amazing!
Please meet Svati Kirsten, a bright shining star journalist and T1D, with her furry daughter, Cabot. What adventures they have … so fun!!! Thank you, Svati, for sharing! I adopted Cabot when she was just 8 weeks old, so have had the pleasure of...
Savvy Updates, 5/10/21: BD “NewCo”, Lilly Smart Insulin Pens, Apple Watch Glucose Tracking, TTP339 Gets Breakthrough Status, Insulin Pill, Walmart Health, Doctor Humor
BD to spin off $1B diabetes care business into standalone public company as reported by Andrea Park for FierceBiotech.com, 6 May 2021. After nearly a century spent building out its portfolio of insulin pens and syringes, BD is finally ready to let its diabetes...
Savvy Drinking, 5/5/21: Happy Cinqo de Mayo … How to Drink Safely PLUS Drs. Edelman & Pettus on Alcohol and Diabetes
Today is Cinqo de Mayo, which commemorates the Mexican Army’s victory over the French Empire at the Battle of Puebla, on May 5, 1862, under the leadership of General Ignacio Zaragoza. Even if this is not your holiday, you can expect to see/hear lots of...
Savvy Updates, 5/3/21: Farxiga for Chronic Kidney Disease, Sernova and the Cure for T1D, Beta Cells Stress Response, T1D 50-year Medalists
FDA Approves Dapagliflozin (Farxiga) for Chronic Kidney Disease was reported by Susan Jeffrey for Medscape.com, 30 April 2021. The US Food and Drug Administration (FDA) has approved dapagliflozin (Farxiga, AstraZeneca) to reduce the risk for...
More Diabetes Blogs